4148 — All Cosmos Bio-Tech Holding Balance Sheet
0.000.00%
- TWD2.73bn
- TWD2.82bn
- TWD2.46bn
- 84
- 54
- 54
- 75
Annual balance sheet for All Cosmos Bio-Tech Holding, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 851 | 775 | 1,346 | 1,571 | 1,106 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 574 | 458 | 728 | 505 | 663 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,827 | 2,302 | 3,367 | 2,818 | 2,661 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 606 | 629 | 679 | 803 | 939 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,614 | 2,970 | 4,111 | 3,674 | 3,671 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 221 | 562 | 682 | 790 | 479 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 628 | 980 | 1,744 | 1,419 | 1,155 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,987 | 1,990 | 2,367 | 2,254 | 2,515 |
| Total Liabilities & Shareholders' Equity | 2,614 | 2,970 | 4,111 | 3,674 | 3,671 |
| Total Common Shares Outstanding |